Frankincense diterpenes as a bio-source for drug discovery

Area of Science:

• Natural Products Chemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Frankincense (Boswellia sp.) gum resins have a long history of use in traditional medicine for conditions like depression, inflammation, and cancer.
• Diterpenoids, including cembrane, prenylaromadendrane, and verticillane types, are key compounds found in Boswellia resins.

Purpose of the Study:

• To review the significance of frankincense diterpenoids, especially incensole derivatives, for future therapeutic applications.
• To explore the potential of these compounds in treating depression, neurological disorders, and cancer.
• To provide an overview of future research perspectives for these molecules.

Main Methods:

• Literature survey of existing studies on Boswellia diterpenoids.
• Analysis of reported biological activities and pharmacological potentials.
• Discussion of challenges and future research directions.

Main Results:

• Cembrane-type diterpenoids exhibit significant biological and pharmacological potential, including anti-Alzheimer, anti-inflammatory, hepatoprotective, and antimalarial effects.
• These compounds show promise for treating anxiety and depression.
• Some limitations regarding selectivity of diterpenoids require further investigation.

Conclusions:

• Frankincense diterpenoids, particularly incensole derivatives, represent a promising area for developing new treatments for neurological disorders and cancer.
• Medicinal chemists should focus on synthesizing incensole-heterocyclic analogs and hybrid compounds for enhanced therapeutic efficacy.
• Addressing selectivity issues in future research is crucial for optimizing the pharmaceutical applications of these natural compounds.